Grown Rogue International (GRUSF) Capital Expenditures (QoQ) (2018 - 2026)
Grown Rogue International (GRUSF) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.00% |
| Dec 31, 2025 | 200.00% |
| Sep 30, 2025 | -136,546,360.61% |
| Jun 30, 2025 | -420.34% |
| Mar 31, 2025 | -100.00% |
| Dec 31, 2024 | 200.00% |
| Sep 30, 2024 | -549,913,118.91% |
| Jun 30, 2024 | 22.47% |
| Mar 31, 2024 | -334.68% |
| Oct 31, 2023 | -103.11% |
| Jul 31, 2023 | -63.03% |
| Apr 30, 2023 | -1,079.16% |
| Jan 31, 2022 | -13.05% |
| Oct 31, 2021 | 44.96% |
| Jul 31, 2021 | -102.40% |
| Apr 30, 2021 | -186.95% |
| Jan 31, 2021 | -470.37% |
| Oct 31, 2020 | -94.80% |
| Jul 31, 2020 | 362.19% |
| Apr 30, 2020 | -7,048.45% |